Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury: editiorial

This editorial refers to ‘Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition’, by K. Yang et al., https://doi.org/10.1093/eurheartj/ehae205.Myocardial ischaemia/reperfusion injury (I/RI) remains...

Full description

Saved in:
Bibliographic Details
Main Authors: Amponsah-Offeh, Michael (Author) , Tual-Chalot, Simon (Author) , Stellos, Konstantinos (Author)
Format: Article (Journal) Editorial
Language:English
Published: 7 May 2024
In: European heart journal
Year: 2024, Volume: 45, Issue: 18, Pages: 1681-1683
ISSN:1522-9645
DOI:10.1093/eurheartj/ehae201
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehae201
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article/45/18/1681/7658561?login=true
Get full text
Author Notes:Michael Amponsah-Offeh, Simon Tual-Chalot, and Konstantinos Stellos

MARC

LEADER 00000caa a2200000 c 4500
001 1906648425
003 DE-627
005 20241205182606.0
007 cr uuu---uuuuu
008 241023s2024 xx |||||o 00| ||eng c
024 7 |a 10.1093/eurheartj/ehae201  |2 doi 
035 |a (DE-627)1906648425 
035 |a (DE-599)KXP1906648425 
035 |a (OCoLC)1475316712 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Amponsah-Offeh, Michael  |d 1990-  |e VerfasserIn  |0 (DE-588)1256146706  |0 (DE-627)1800317093  |4 aut 
245 1 0 |a Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury  |b editiorial  |c Michael Amponsah-Offeh, Simon Tual-Chalot, and Konstantinos Stellos 
264 1 |c 7 May 2024 
300 |b Illustrationen 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 26. April 2024 
500 |a Gesehen am 23.10.2024 
520 |a This editorial refers to ‘Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition’, by K. Yang et al., https://doi.org/10.1093/eurheartj/ehae205.Myocardial ischaemia/reperfusion injury (I/RI) remains a formidable challenge in cardiovascular medicine, necessitating a deeper understanding of the molecular mechanisms at play. Myocardial I/RI pathophysiology involves complex interactions between oxidative stress, cell death, and inflammation.1 Myocardial ischaemia often occurs in individuals who exhibit symptoms of an acute ST-segment elevation myocardial infarction (STEMI).1 The most efficient therapeutic approach for diminishing acute myocardial ischaemic injury in these patients and mitigating the extent of myocardial infarction is prompt opening of the occluded coronary artery by primary percutaneous coronary intervention. Reperfusion strategies, while being the standard therapy for acute myocardial infarction, can result in various forms of IR/I, including reperfusion-induced arrhythmias, myocardial stunning, microvascular obstruction, and thrombosis.1 Despite advances in these revascularization therapies, the extent of myocardial damage and adverse left ventricular remodelling, reflected by significant mortality (7% death at 1 year) and morbidity (22% prolonged or new hospitalization for heart failure at 1 year), compromise the survival and quality of life in STEMI patients.1,2 Therefore, understanding the pathophysiology of myocardial I/RI is critical in addressing the unmet need for novel therapeutic strategies to protect the heart and improve the clinical outcomes of these patients. 
700 1 |a Tual-Chalot, Simon  |e VerfasserIn  |0 (DE-588)1319031323  |0 (DE-627)1880506971  |4 aut 
700 1 |a Stellos, Konstantinos  |d 1981-  |e VerfasserIn  |0 (DE-588)133214354  |0 (DE-627)538682132  |0 (DE-576)272835803  |4 aut 
773 0 8 |i Enthalten in  |t European heart journal  |d Oxford : Oxford University Press, 1980  |g 45(2024), 18, Seite 1681-1683  |h Online-Ressource  |w (DE-627)320415813  |w (DE-600)2001908-7  |w (DE-576)103746846  |x 1522-9645  |7 nnas  |a Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury editiorial 
773 1 8 |g volume:45  |g year:2024  |g number:18  |g pages:1681-1683  |g extent:3  |a Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury editiorial 
856 4 0 |u https://doi.org/10.1093/eurheartj/ehae201  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://academic.oup.com/eurheartj/article/45/18/1681/7658561?login=true  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20241023 
993 |a Editorial 
994 |a 2024 
998 |g 133214354  |a Stellos, Konstantinos  |m 133214354:Stellos, Konstantinos  |d 60000  |d 65000  |e 60000PS133214354  |e 65000PS133214354  |k 0/60000/  |k 1/60000/65000/  |p 3  |y j 
998 |g 1256146706  |a Amponsah-Offeh, Michael  |m 1256146706:Amponsah-Offeh, Michael  |d 60000  |d 65000  |e 60000PA1256146706  |e 65000PA1256146706  |k 0/60000/  |k 1/60000/65000/  |p 1  |x j 
999 |a KXP-PPN1906648425  |e 4601651484 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title":"European heart journal","title_sort":"European heart journal"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury editiorialEuropean heart journal","note":["Gesehen am 12.09.2017"],"recId":"320415813","language":["eng"],"pubHistory":["1.1980 -"],"part":{"pages":"1681-1683","issue":"18","year":"2024","extent":"3","volume":"45","text":"45(2024), 18, Seite 1681-1683"},"origin":[{"publisherPlace":"Oxford ; London [u.a.]","dateIssuedDisp":"1980-","dateIssuedKey":"1980","publisher":"Oxford University Press ; Harcourt"}],"id":{"eki":["320415813"],"zdb":["2001908-7"],"issn":["1522-9645"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"noteIll":"Illustrationen","extent":"3 S."}],"name":{"displayForm":["Michael Amponsah-Offeh, Simon Tual-Chalot, and Konstantinos Stellos"]},"id":{"eki":["1906648425"],"doi":["10.1093/eurheartj/ehae201"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"7 May 2024"}],"language":["eng"],"recId":"1906648425","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online verfügbar: 26. April 2024","Gesehen am 23.10.2024"],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Amponsah-Offeh, Michael","given":"Michael","family":"Amponsah-Offeh"},{"roleDisplay":"VerfasserIn","display":"Tual-Chalot, Simon","role":"aut","family":"Tual-Chalot","given":"Simon"},{"roleDisplay":"VerfasserIn","display":"Stellos, Konstantinos","role":"aut","family":"Stellos","given":"Konstantinos"}],"title":[{"subtitle":"editiorial","title":"Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury","title_sort":"Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury"}]} 
SRT |a AMPONSAHOFREPURPOSIN7202